These updated guidelines from the British Association for Psychopharmacology replace the
original version published in 2011. They address the scope and targets of pharmacological …

Psychiatric conditions (including substance misuse disorders) are serious, potentially life
threatening illnesses that can be successfully treated by psychotropic drugs, even during …

Decisions about the use of psychotropic medication in pregnancy are an ongoing challenge
for clinicians and women with mental health problems, owing to the uncertainties around …

Objective To evaluate neurodevelopment, growth, and health outcomes in infants receiving
bovine milk fat globule membrane (MFGM) and lactoferrin in infant formula. Study design …

Importance Psychiatric disorders are common among female individuals of reproductive
age. While antipsychotic medication use is increasing, the safety of such medications in …

Background There is extensive lack of awareness of maternal mental health and its impact
on child development in low-and middle-income countries (LAMICs). The aim of this …

The issue of antipsychotic treatment during pregnancy is subject to substantial uncertainty
and some controversy among healthcare providers, specifically pertaining to second …

This paper reviews the findings from preclinical animal and human clinical research
investigating maternal/fetal, neonatal, and child neurodevelopmental outcomes following …

To review available data on first‐trimester exposure to olanzapine, quetiapine, risperidone
and aripiprazole and risk of congenital malformations. We performed a systematic literature …

Objective: To summarize risks related to (1) illness and (2) second-generation antipsychotic
(SGA) treatment in pregnant women and their offspring. Concerning illness-related risks, we …